Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	36.4	34.81	29.43	39.14	43.84	11.23
Short-Term Investments	719.6	388.78	275.52	369.11	150.59	53.15
Cash & Short-Term Investments	756	423.6	304.95	408.25	194.42	64.38
Cash Growth	221.23%	38.91%	-25.30%	109.98%	201.98%	-31.52%
Receivables	0.85	2.63	0.35	0.17	1.8	1.02
Prepaid Expenses	21.99	5.47	12.39	2.42	1.62	1.3
Total Current Assets	778.84	431.69	317.69	410.84	197.84	66.7
Property, Plant & Equipment	7.4	6.64	7.75	6.52	7.26	7.5
Other Intangible Assets	27.19	27.19	27.19	27.19	30.69	48.69
Other Long-Term Assets	9.75	0.11	0.1	0.1	0.04	0.04
Total Assets	823.18	465.63	352.74	444.65	235.84	122.93
Accounts Payable	1.11	3.49	3.34	1.23	1.05	1.17
Accrued Expenses	28.2	22.03	12.84	12	8.46	6.5
Current Portion of Leases	1.38	1.61	1.45	1.75	1.33	1.94
Current Unearned Revenue	-	3.06	0.06	0.43	-	-
Other Current Liabilities	1.4	0.93	0.93	1.12	3.37	2.03
Total Current Liabilities	32.09	31.13	18.61	16.53	14.21	11.64
Long-Term Leases	1.71	0.93	2.59	1.3	2.15	1.71
Other Long-Term Liabilities	3.47	4.4	5.33	7.35	10.12	15.55
Total Liabilities	37.27	36.46	26.53	25.18	26.48	28.91
Common Stock	0.07	0.06	0.05	0.05	0.04	0.02
Additional Paid-In Capital	2,289	1,823	1,581	1,561	1,280	1,105
Retained Earnings	-1,508	-1,397	-1,256	-1,144	-1,073	-1,013
Comprehensive Income & Other	5.29	3.31	1.26	1.89	2.59	2.62
Shareholders' Equity	785.91	429.17	326.2	419.48	209.36	94.03
Total Liabilities & Equity	823.18	465.63	352.74	444.65	235.84	122.93
Total Debt	3.09	2.54	4.03	3.04	3.48	3.66
Net Cash (Debt)	752.91	421.06	300.92	405.21	190.94	60.73
Net Cash Growth	223.83%	39.92%	-25.74%	112.22%	214.43%	-35.41%
Net Cash Per Share	12.38	8.69	6.42	9.45	6.44	4.19
Filing Date Shares Outstanding	66.34	55.9	47.21	46.74	39.61	17.57
Total Common Shares Outstanding	66.34	55.88	47.2	46.73	39.6	16.97
Working Capital	746.75	400.57	299.08	394.31	183.64	55.06
Book Value Per Share	11.85	7.68	6.91	8.98	5.29	5.54
Tangible Book Value	758.72	401.98	299.01	392.29	178.67	45.34
Tangible Book Value Per Share	11.44	7.19	6.33	8.39	4.51	2.67
Machinery	-	16.01	15.26	14.51	14.61	15.01
Construction In Progress	-	0.79	0.5	0.63	0.34	0.19
Leasehold Improvements	-	9.65	9.61	9.53	10.1	17.24

Source: S&P Capital IQ. Standard template. Financial Sources.